Lack of observed association between high plasma osteoprotegerin concentrations and ischemic stroke risk in a healthy population by Nybo, Mads et al.
EDITORIALS
Newborn Screening for Wilson Disease: Does Liquid
Chromatography–Tandem Mass Spectrometry
Provide the Solution? W.A. Gahl (see article on
page 1961) 1941
What Kind of Stroke Is It? M.D. Hill (see article on
page 1969) 1943
PERSPECTIVES
Genetic Variations in UDP-Glucuronosyl Transferase
2B17: Implications for Testosterone Excretion
Profiling and Doping Control Programs B. Starcevic
and A.W. Butch 1945
Molecular Genotyping in Transfusion Medicine
C.M. Westhoff and S.R. Sloan 1948
SPECIAL REPORT
National Academy of Clinical Biochemistry
Laboratory Medicine Practice Guidelines for Use of
Tumor Markers in Testicular, Prostate, Colorectal,
Breast, and Ovarian Cancers C.M. Sturgeon,
M.J. Duffy, U.-H. Stenman, H. Lilja, N. Bru¨nner,
D.W. Chan, R. Babaian, R.C. Bast, Jr., B. Dowell,
F.J. Esteva, C. Haglund, N. Harbeck, D.F. Hayes,
M. Holten-Andersen, G.G. Klee, R. Lamerz,
L.H. Looijenga, R. Molina, H.J. Nielsen,
H. Rittenhouse, A. Semjonow, I.-M. Shih, P. Sibley,
G. So¨le´tormos, C. Stephan, L. Sokoll, B.R. Hoffman,
and E.P. Diamandis e11
REVIEW
Emerging Biomarkers for the Diagnosis and
Prognosis of Prostate Cancer G. Sardana, B. Dowell,
and E.P. Diamandis 1951
ARTICLES
PROTEOMICS AND PROTEIN MARKERS
Tryptic Peptide Analysis of Ceruloplasmin in Dried
Blood Spots Using Liquid Chromatography–Tandem
Mass Spectrometry: Application to Newborn
Screening A. deWilde, K. Sadilkova, M. Sadilek,
V. Vasta, and S.H. Hahn (see editorial on page 1941) 1961
LIPIDS, LIPOPROTEINS, AND CARDIOVASCULAR
RISK FACTORS
Lack of Observed Association between High Plasma
Osteoprotegerin Concentrations and Ischemic
Stroke Risk in a Healthy Population M. Nybo,
S.P. Johnsen, C. Dethlefsen, K. Overvad,
A. Tjønneland, J.O.L. Jørgensen, and L.M. Rasmussen
(see editorial on page 1943) 1969
Association of Lipoprotein-Associated
Phospholipase A2 Mass and Activity with Coronary
and Aortic Atherosclerosis: Findings from the Dallas
Heart Study E.S. Brilakis, A. Khera, B. Saeed,
S. Banerjee, D.K. McGuire, S.A. Murphy, and
J.A. de Lemos 1975
ANIMAL CLINICAL CHEMISTRY
Analytical Characteristics of Commercial Cardiac
Troponin I and T Immunoassays in Serum from
Rats, Dogs, and Monkeys with Induced Acute
Myocardial Injury F.S. Apple, M.M. Murakami,
R. Ler, D. Walker, and M. York, for the HESI
Technical Committee of Biomarkers Working Group
on Cardiac Troponins 1982
AUTOMATION AND ANALYTICAL TECHNIQUES
Simultaneous Measurement of Plasma
Concentrations of Proinsulin and C-Peptide and
Their Ratio with a Trefoil-Type Time-Resolved
Fluorescence Immunoassay P.E.M. De Pauw,
I. Vermeulen, O.C. Ubani, I. Truyen, E.M.F. Vekens,
F.T. van Genderen, J.W. De Grijse, D.G. Pipeleers,
C. Van Schravendijk, and F.K. Gorus 1990
CANCER DIAGNOSTICS
Clinical Impact of New Prostate-Specific Antigen
WHO Standardization on Biopsy Rates and Cancer
Detection F.H. Jansen, M. Roobol, C.H. Bangma, and
R.H.N. van Schaik 1999
Performance of a Single Assay for Both Type III and
Type VI TMPRSS2:ERG Fusions in Noninvasive
Prediction of Prostate Biopsy Outcome J.P. Clark,
K.W. Munson, J.W. Gu, K. Lamparska-Kupsik,
K.G. Chan, J.S. Yoshida, M.H. Kawachi, L.E. Crocitto,
T.G. Wilson, Z. Feng, and S.S. Smith 2007
Clinical Chemistry Contents Volume 54, Number 12, Pages 1941–2097 DECEMBER 2008
continued
Clinical Chemistry (ISSN 0009-9147) is published monthly by the American Association for Clinical Chemistry, 1850 K Street, NW, Suite 625, Washington, DC 20006. New subscriptions, renewals, changes of address, back issues,
and all customer service questions should be addressed to: AACC, Subscription Department, 1850 K Street, NW, Suite 625, Washington, DC 20006. Telephone (202) 857-0717 or 1 (800) 892-1400; fax (202) 887-5093; e-mail
custserv@aacc.org. Subscription rates: Institutional subscription USA $992, elsewhere $1,144. Individual subscription USA $299, elsewhere $464. Airmail delivery outside USA is an additional $270. Individual subscriptions are for
personal use and not to be used in a library. Periodicals postage paid at Washington, DC and at additional mailing offices. Postmaster: Send address changes to Clinical Chemistry, 1850 K Street, NW, Suite 625, Washington, DC
20006. Copyright © 2008 The American Association for Clinical Chemistry.
ARTICLES, continued
DRUG MONITORING AND TOXICOLOGY
Meconium Nicotine and Metabolites by Liquid
Chromatography–Tandem Mass Spectrometry:
Differentiation of Passive and Nonexposure and
Correlation with Neonatal Outcome Measures
T.R. Gray, R. Magri, D.M. Shakleya, and M.A. Huestis 2018
GENERAL CLINICAL CHEMISTRY
Quantification of Methylmalonic Acid in
Human Plasma with Hydrophilic Interaction
Liquid Chromatography Separation and Mass
Spectrometric Detection H.-Å. Lakso, P. Appelblad,
and J. Schneede 2028
HEMATOLOGY
Newborn Screening for Sickle Cell Disease Using
Tandem Mass Spectrometry F. Boemer,
O. Ketelslegers, J.-M. Minon, V. Bours, and R. Schoos 2036
HEMOSTASIS AND THROMBOSIS
Prediction of Recurrent Venous Thromboembolism
by Endogenous Thrombin Potential and D-Dimer
S. Eichinger, G. Hron, M. Kollars, and P.A. Kyrle 2042
LABORATORY MANAGEMENT
Assessing the Impact of the Frequency of Quality
Control Testing on the Quality of Reported Patient
Results C.A. Parvin 2049
BRIEF COMMUNICATIONS
High-Resolution Melting Curve Analysis of Genomic
and Whole-Genome Amplified DNA M.H. Cho,
D. Ciulla, B.J. Klanderman, B.A. Raby, and
E.K. Silverman 2055
Automated Measurement of 25-OH Vitamin D3 on
the Roche Modular E170 Analyzer A. Leino,
U. Turpeinen, and P. Koskinen 2059
Seminal Oligouridinosis: Low Uridine Secretion as a
Biomarker for Infertility in Spinal Neurotrauma
A.D. Maher, P. Patki, J.C. Lindon, E.J. Want,
E. Holmes, M. Craggs, and J.K. Nicholson 2063
Tandem Mass Spectrometry for the Direct Assay of
Lysosomal Enzymes in Dried Blood Spots:
Application to Screening Newborns for
Mucopolysaccharidosis I S. Blanchard, M. Sadilek,
C.R. Scott, F. Turecek, and M.H. Gelb 2067
CLINICAL CASE STUDY
Hemolytic Anemia Following Attempted Suicide
N.L. Korpi-Steiner, J.B. Hoyne, J.D. Hoyer, and
A.K. Saenger 2071
COMMENTARIES
E. Beutler 2074
I.D. Watson 2075
CITATION CLASSIC
Liquid-Chromatographic Determination of
Cyclosporin A in Blood and Plasma R.J. Sawchuk 2076
LETTERS TO THE EDITOR
Time-Dependent Instability of Cardiac Troponins in
Human Plasma Spiked with NIST Reference Material
2921 C.M. Cobbaert, C.W. Weykamp,
E.C.H.J. Michielsen, H. Baadenhuijsen, and
M.P. van Dieijen-Visser 2078
Galactosemia Screening by Simultaneous Blood
Spot Quantification of Galactose and Galactose
1-Phosphate J.-S. Jeong, H.-J. Kwon, Y.-M. Lee,
H.-R. Yoon, and S.-P. Hong 2080
Interlaboratory Variation in 25-Hydroxyvitamin D2
and 25-Hydroxyvitamin D3 Is Significantly Improved
If Common Calibration Material Is Used A.M. Yates,
A. Bowron, L. Calton, J. Heynes, H. Field, S. Rainbow,
and B. Keevil 2082
Potential Interference by Antineutrophil
Cytoplasmic Autoantibodies in Myeloperoxidase
Immunoassays S.A. Datwyler, S.C. Hsu, M.S. Matias,
D.P. Pacenti, and J. Shih 2084
Concerns Regarding Lipoprotein Particle
Measurement by Ion Mobility Analysis J.D. Otvos,
L.L. Rudel, and J.P. McConnell 2086
Clinical Chemistry Contents Volume 54, Number 12, Pages 1941–2097 DECEMBER 2008
continued
LETTERS TO THE EDITOR, continued
Protein Microarrays: Before the Elephant Got in the
Room J. Gordon 2087
In Reply M.P. Caulfield, S. Li, G. Lee, P.A. Blanche,
W.A. Salameh, W.H. Benner, R.E. Reitz,
and R.M. Krauss 2088
BOOKSHELF
Markers in Cardiology: A Case-Oriented Approach.
Jesse E. Adams, Fred S. Apple, and Allan S. Jaffe,
Editors. J. Ravkilde 2090
CLINICAL CHEMIST
The Death of Napolean, Cancer or Arsenic?
J.T. Hindmarsh and J. Savory 2092
Who Says Learning Toxicology Can’t Be Fun? 2094
INVITED REVIEWERS 2008 2095
ACCENT—CONTINUING EDUCATION CREDIT FOR
READERS OF CLINICAL CHEMISTRY
For more information go to
http://apps.aacc.org.ccj/accent
ON THE COVER Dr. Roussell of Ge-
neva shown here giving a woman a
direct blood transfusion from a volun-
teer, 1882. With the many advances in
modern medicine, it is easy to forget
how transfusion medicine was per-
formed prior to 1900. When Land-
steiner published his Nobel Prizewinningwork on themajor
ABOblood groups in 1901, it became possible to crossmatch
donors and recipients, thus greatly reducing transfusion re-
actions. Since that time surface antigen systems such as Rh,
Lutheran, Kell, Lewis, Duffy, and Kidd have been described.
Antibody-based methods traditionally have been the pri-
mary approach to blood group testing. However, with the
availability of genotyping technologies,Westhoff and Sloan
describe in this issue of Clinical Chemistry how transfusion
medicine is poised to benefit from the PCR revolution (see
page 1948). Reprinted with permission © The Print Collector/
Heritage-Images/Imagestate.
Color figures for Reviews sponsored by Department of Labora-
tory Medicine, Children’s Hospital Boston.
Clinical Chemistry Contents Volume 54, Number 12, Pages 1941–2097 DECEMBER 2008
